PGY2 Infectious Diseases Pharmacy Residency Program


The UTMB Health PGY2 Infectious Diseases pharmacy residency program is designed to prepare PGY1 pharmacy residency graduates for a career focused in the care of patients with infectious diseases.  Residents will have the opportunity to develop knowledge and skills in infectious diseases and clinical microbiology.  The PGY2 resident will work closely with the Adult Infectious Diseases Consult Service and other clinical services.


The resident will also be a member of the health system’s Antimicrobial Stewardship Committee and have the opportunity to learn, establish, and perform evidence-based antimicrobial stewardship strategies to optimize antibiotic use throughout the institution.


The resident will expand his/her teaching skills by interacting with students from four area colleges of pharmacy. Residency projects are presented as posters at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition and as a platform presentation at Alcáldé, a regional residency conference.


The PGY2 Infectious Diseases pharmacy residency program is currently in candidate status by the (ASHP).  The program code is 74127.


Preceptors 2018-2019

UTMB Health ASHP-accredited PGY2 - INFECTIOUS dISEASES Pharmacy Residency Program Outcomes

  1. Providing safe and effective patient care to a diverse range of patients in collaboration with the health care team
  2. Establish and perform evidence-based antimicrobial stewardship strategies
  3. Exercising leadership and management skills
  4. Provide teaching, education, and dissemination of knowledge

Program Structure 2020-2021*

The purpose of this structure is to comply with the PGY2 program purpose: PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training. 

Orientation Required RotationsElective Rotations
First month of the residency (July)
Residency Project Selection
On-line Training
Inpatient Pharmacy
  • Central pharmacy
  • Compounding
  • Narcotics/vault
  • Robot/carousel
IV Room
Epic EMR
TPN class
Bugs and Drugs
Policy Review
Staffing Competencies

5 rotations
Infectious Diseases Consult  Antimicrobial Stewardship - 2 blocks (5 weeks each)
Microbiology (3 weeks) 
Infectious Disease Internal Medicine (4 weeks)
  HIV primary team
Neonatal/Pediatric Infectious Diseases (4 weeks)




5 rotations
Intensive Care Unit (4 weeks)
  Medical or Surgical
Solid Organ Transplant (4 weeks)
Emergency Medicine (4 weeks)
Hematology/Oncology (4 weeks)







Longitudinal Practice Experiences

  • ID Outpatient (January-June)
  • Residency Project (July-June)
  • Medication Use Evaluation (approximately 6 months)
  • On-call Responsibilities (September-June)
All longitudinal practice experiences occur between July and June of the residency year

Updated: 10/24/2019

* The resident will spend at least 2/3 of his/her time in direct patient care. Direct patient care by pharmacists will be defined as activities performed by pharmacists with the intent of contributing to positive pharmacotherapeutic and health outcomes of individual patients. Care is in collaboration and communication with other members of the health care team with responsibilities for the individual patient and is achieved directly with patients and caregivers face-to-face, telephonically, virtually, or in writing.

†The learning experiences are typically sequenced per discussion with the resident and RPD, based upon resident interests and rotations completed as a student, and preceptor availability. The first 5 rotations are scheduled in July and the final 5 rotations are scheduled in December after the Midyear Clinical Meeting.